HIF2驱动的PTHrP在癌中引起白内障和高热血症:用HIF2抑制剂治疗
Muhannad Abu-Remaileh1,2, Laura A Stransky1, Nikita Bhalerao3
1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
bioRxiv : the preprint server for biology
|September 18, 2025
概括
在癌中,pVHL的损失会提高HIF2的调节,从而导致PTHLH的表达. 这会导致高血症和缓解症,这些都是由HIF2抑制剂逆转的.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 清细胞细胞癌 (ccRCC) 是最常见的癌.
- 瘤综合征,如高热血症和硬血症在癌中很常见,但人们对其了解甚少.
- 失去pVHL瘤抑制蛋白和随后的HIF2上调是ccRCC中的关键事件.
研究的目的:
- 调查在ccRCC中链接pVHL损失,HIF2和副瘤综合征的机制.
- 确定PTHLH在ccRCC相关的高血症和缓解症中的作用.
- 评估HIF2抑制剂在治疗这些副瘤综合征中的疗效.
主要方法:
- 在ccRCC中分析PTHLH作为直接的HIF2转录标.
- 使用临床前正确细胞系瘤模型来评估PTHLH的必要性和充分性.
- 在ccRCC患者中对HIF2抑制剂 (belzutifan和NKT2152) 的临床评估,这些患者患有高血症和缓冲症.
主要成果:
- 在ccRCC中,PTHLH是直接的HIF2转录标.
- 增加PTHLH表达是必要的,并且足以在ccRCC模型中诱导高血症和缓解症.
- 在ccRCC患者中,HIF2抑制剂迅速改善了高血症和血症,而不管瘤缩小.
结论:
- 由HIF2驱动的PTHLH表达是ccRCC中副瘤综合征的关键机制.
- 用抑制剂向HIF2提供了一种治疗策略,用于治疗癌患者的高血症和缓解症.
相关概念视频
Chronic Kidney Disease II: Clinical Manifestations
557
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
557
Hormones and Bone Tissue
3.7K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.7K
Chronic Kidney Disease III: Interprofessional Care
344
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
344
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
447
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
447
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Acute Kidney Injury II: Pathophysiology
903
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
903


